This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...